Iridex director William Moore buys $29,121 in stock

Published 13/06/2025, 18:36
Iridex director William Moore buys $29,121 in stock

In recent transactions, William M. Moore, a director at Iridex Corp (NASDAQ:IRIX), purchased a total of 30,000 shares of common stock over two days. The insider buying comes as the stock trades near $0.96, having declined over 45% in the past six months. According to InvestingPro analysis, the company currently trades below its Fair Value, though it faces challenges with negative EBITDA of -$4.94M. The acquisitions were made on June 11 and June 12, 2025, at prices ranging from $0.9627 to $0.9747 per share. The total value of these purchases amounts to $29,121. Following these transactions, Moore directly owns 168,650 shares. Additionally, Moore holds indirect ownership of 99,326 shares, with 69,300 shares held by his spouse and 30,026 shares held in a trust. InvestingPro has identified several key metrics for IRIX, including that it’s quickly burning through cash. Subscribers can access 6 additional ProTips and a comprehensive Pro Research Report, part of the analysis available for 1,400+ US stocks.

In other recent news, IRIDEX Corporation announced its financial results for the fourth quarter of 2024, reporting a net loss of $800,000, or $0.05 per share, which met market expectations. The company achieved revenue of $12.7 million, slightly exceeding forecasts, and reported positive adjusted EBITDA for the first time. Meanwhile, IRIDEX received a notification from Nasdaq regarding non-compliance with the minimum stockholder equity requirement, with plans to address this through shareholder approval to reclassify certain stock at an upcoming meeting. The company also amended an agreement with Novel Inspiration International, preventing significant asset disposals without unanimous board consent. Recent board changes include the resignations of directors Kenneth E. Ludlum and Robert E. Grove, in line with agreements made with Novel Inspiration International. These corporate governance updates are part of IRIDEX’s strategic partnership with Novel, which has influenced its board composition. The company continues to navigate compliance and strategic initiatives while maintaining its business operations and SEC reporting requirements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.